ADIL Adial Pharmaceuticals Inc. Earnings growth forecast for next year

ADIL (Adial Pharmaceuticals, Inc.) - company brandmark

The reduction of clinical risks through genetic patient selection for addiction therapy has defined the vector of forward net income expectations, where the indicator stands at 76.00. This is supported by the success of Adial Pharmaceuticals (ADIL) AD04 trials and its expansion into Europe. Optimized component deliveries and reliable warehouse reserves, which eliminate supply disruptions, ensure price stability.

ADIL: Adial Pharmaceuticals Inc. Consensus forecast of earnings per share growth for next year 07/04/2022 - 10/29/2026

Comprehensive metric breakdowns and analytics for Adial Pharmaceuticals (ADIL)

- share price and consensus valuation forecast:
Stock Price Adial|ADIL - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Adial Pharmaceuticals, Inc.|ADIL - Business Value
- book capitalization indicators:
Book Value per Share Adial Pharmaceuticals|ADIL - Book Valuation of Business|Market Capitalization to Book Value Ratio adialpharma.com|ADIL - Company Total Assets
- debt obligations and liquidity statistics:
Debt to Equity Adial Pharmaceuticals|ADIL - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio adialpharma.com|ADIL - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Adial Pharmaceuticals, Inc.|ADIL - Long-Term Liabilities|Company Short-Term Debts Adial Pharmaceuticals|Quick Ratio adialpharma.com
- earnings and valuation multiples information:
ADIL - Net Profit|Expected Profit Adial Pharmaceuticals|ADIL - Company Value to Net Income|Future Price to Earnings adialpharma.com|ADIL - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Adial Pharmaceuticals, Inc.|ADIL - Operating profit EBITDA|Net earnings per share (EPS TTM) Adial Pharmaceuticals|ADIL - Net earnings per share for the last 12 months|Quarterly EPS earnings growth adialpharma.com|ADIL - Earnings per share growth rate in current year|Expected earnings per share growth for next year Adial Pharmaceuticals
- revenue and sales details:
ADIL - Revenue and Sales Volume|Company Future Sales Volume Adial Pharmaceuticals Inc.|ADIL - Market Cap to Sales Volume|Forward P/S Multiple Adial Pharmaceuticals, Inc.
Fundamental company valuation:ADIL, adialpharma.com
Core merchandise of Adial

Institutional interest in Adial Pharmaceuticals (ADIL) depends on the company's ability to monetize its developments in addiction therapy, where a profit growth forecast of 76.00 determines its investment attractiveness. This benchmark for the company's EPS dynamics for the coming year aggregates analyst consensus forecasts for earnings per share, allowing for an assessment of business resilience when scaling personalized alcoholism treatment.

Who Adial Pharmaceuticals competes with

INDV (indivior.com) - Earnings growth forecast for next year|Expected earnings per share growth for next year collegiumpharma.com (COLL)|Net earnings per share growth forecast for next year Cronos Group (CRON)|Canopy Growth Corp - Projected earnings per share growth rate for next year|Earnings growth forecast for next year HITI (High Tide Inc)|Aurora Cannabis (ACB) - Expected net earnings per share growth next year|achievelifesciences.com - Earnings growth forecast for next year|Expected net earnings per share growth next year Skye Bioscience|ANEB (anebulo.com) - Expected earnings per share growth for next year|InterCure Ltd - Expected earnings per share trend next year|NTRB (Nutriband Inc.) - Earnings growth forecast for next year|NSRX: Expected earnings per share trend next year|Net earnings per share growth forecast for next year India Globalization Capital (IGC)|MIRA (MIRA Pharmaceuticals, Inc.) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Flora Growth FLGC|Earnings growth forecast for next year IMC IMCC|Artelo Biosciences Inc. - Earnings growth forecast for next year|ENSC: Net earnings per share growth forecast for next year|Titan Pharma (TTNP) - Net earnings per share growth forecast for next year|Greenlane Holdings - Expected earnings per share trend next year|INM (inmedpharma.com) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year AKAN (Akanda Corp.)|Net earnings per share growth forecast for next year Enveric Corp (ENVB)|Bright Green Corporation - Projected earnings per share growth rate for next year|Hempacco Co., Inc. - Expected earnings per share growth for next year